177 related articles for article (PubMed ID: 37490089)
1. Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems-Reply.
Meaidi A; Torp-Pedersen C; Mørch LS
JAMA; 2023 Jul; 330(4):378-379. PubMed ID: 37490089
[No Abstract] [Full Text] [Related]
2. Ectopic Pregnancy Risk and Levonorgestrel-Releasing Intrauterine Systems.
Jugl S; Winterstein AG
JAMA; 2023 Jul; 330(4):378. PubMed ID: 37490092
[No Abstract] [Full Text] [Related]
3. Heterotopic cesarean scar pregnancy associated with a levonorgestrel-releasing intrauterine device.
Dueñas-Garcia OF; Young C
Int J Gynaecol Obstet; 2011 Aug; 114(2):153-4. PubMed ID: 21679948
[No Abstract] [Full Text] [Related]
4. Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone.
Meaidi A; Torp-Pedersen C; Lidegaard Ø; Mørch LS
JAMA; 2023 Mar; 329(11):935-937. PubMed ID: 36943224
[TBL] [Abstract][Full Text] [Related]
5. IUDs and ectopic pregnancy.
Sivin I
Contraception; 1995 Nov; 52(5):321-2. PubMed ID: 8585891
[No Abstract] [Full Text] [Related]
6. Levonorgestrel intrauterine contraceptive systems (13.5 mg and 52 mg) and risk of ectopic pregnancy.
Graner S; Mc Taggart J; Nordström F; Melander E; Widenberg J; Kopp Kallner H
Acta Obstet Gynecol Scand; 2019 Jul; 98(7):937-943. PubMed ID: 30737766
[TBL] [Abstract][Full Text] [Related]
7. Jaydess® levonorgestrel intrauterine system.
Melvin L; Scott J; Craik J
J Fam Plann Reprod Health Care; 2014 Jul; 40(3):165-9. PubMed ID: 24939481
[No Abstract] [Full Text] [Related]
8. Failed cervical pregnancy with levonorgestrel containing intrauterine contraceptive device.
Trivedi AN; Ngu A
Aust N Z J Obstet Gynaecol; 2002 May; 42(2):210-1. PubMed ID: 12069152
[No Abstract] [Full Text] [Related]
9. [Intrauterine system (Mirena) and ectopic pregnancy--case report].
Dvořák J; Toman A
Ceska Gynekol; 2012 Oct; 77(5):414-5. PubMed ID: 23116345
[TBL] [Abstract][Full Text] [Related]
10. Primary ovarian pregnancy with a levonorgestrel intrauterine system.
Kalu E; Disu S; Gordon-Wright H; Pisal N
J Fam Plann Reprod Health Care; 2006 Oct; 32(4):253-4. PubMed ID: 17032519
[No Abstract] [Full Text] [Related]
11. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
Luukkainen T; Toivonen J
Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
[TBL] [Abstract][Full Text] [Related]
12. The 13.5-mg, 19.5-mg, and 52-mg Levonorgestrel-Releasing Intrauterine Systems and Risk of Ectopic Pregnancy.
Elgemark K; Graner S; McTaggart J; Ramirez Löfström J; Sörensen D; Envall N; Kopp Kallner H
Obstet Gynecol; 2022 Aug; 140(2):227-233. PubMed ID: 35852273
[TBL] [Abstract][Full Text] [Related]
13. Is there evidence to treat bleeding disturbances during long-term 52 mg LNG-IUS use with estrogen?
der Heijden PAHHV; Bui BN; Veersema S; Geomini PMAJ; Bongers MY
Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():217-219. PubMed ID: 31917006
[No Abstract] [Full Text] [Related]
14. Continuation Rates of the 52-mg Levonorgestrel-releasing Intrauterine System according to the Primary Reason for its Use.
Miranda L; Sousa MH; Faundes A; Juliato C
Rev Bras Ginecol Obstet; 2021 Apr; 43(4):291-296. PubMed ID: 33979890
[TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Song SY; Lee SY; Kim HY; Park DB; Kim DE; Lee KH; Lee S; Yang JB; Yoo HJ
Medicine (Baltimore); 2020 May; 99(22):e20421. PubMed ID: 32481439
[TBL] [Abstract][Full Text] [Related]
16. Experience with same-day placement of the 52 mg levonorgestrel-releasing intrauterine system.
Castaño PM; Westhoff CL
Am J Obstet Gynecol; 2020 Apr; 222(4S):S883.e1-S883.e6. PubMed ID: 31945336
[TBL] [Abstract][Full Text] [Related]
17. Levonorgestrel-releasing intrauterine system versus endometrial ablation for heavy menstrual bleeding.
Beelen P; van den Brink MJ; Herman MC; Geomini PMAJ; Dekker JH; Duijnhoven RG; Mak N; van Meurs HS; Coppus SF; van der Steeg JW; Eising HP; Massop-Helmink DS; Klinkert ER; Nieboer TE; Timmermans A; van der Voet LF; Veersema S; Smeets NAC; Schutte JM; van Baal M; Bossuyt PM; Mol BWJ; Berger MY; Bongers MY
Am J Obstet Gynecol; 2021 Feb; 224(2):187.e1-187.e10. PubMed ID: 32795428
[TBL] [Abstract][Full Text] [Related]
18. Long-term experience of a levonorgestrel-releasing intrauterine system.
Odlind V
Eur J Contracept Reprod Health Care; 1996 Dec; 1(4):319-23. PubMed ID: 9678114
[TBL] [Abstract][Full Text] [Related]
19. Marked increase of breast density due to a levonorgestrel-releasing intrauterine device.
Gossner J
JBR-BTR; 2013; 96(6):396. PubMed ID: 24617194
[No Abstract] [Full Text] [Related]
20. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
Nelson A; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Gemzell-Danielsson K
Obstet Gynecol; 2013 Dec; 122(6):1205-13. PubMed ID: 24240244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
